Literature DB >> 25609482

[Update on genetic predisposition to prostate cancer].

Olivier Cussenot1, Géraldine Cancel-Tassin2.   

Abstract

Genetic predisposition to prostate cancer rarely corresponds to a high penetrance Mendelian pattern of inheritance. These hereditary forms are specific entities for which mutations in the BRCA2 gene, the HOXB13 gene (variant G84E) or, to a lesser extent BRCA1 gene, must be researched. In contrast, the genetic component of the majority of prostate cancer is polygenic, involving an unfavorable combination of common genetic variants, resulting from a mixture of the genetic inheritance of the father and the mother. One hundred of these genetic susceptibility variants have now been identified and validated. The main phenotypic trait associated with hereditary predisposition is the younger age at onset, which warrants special monitoring in order to stay in the window of curability at diagnosis. The psychological impact of a family history of prostate cancer or breast cancer favors the establishment of a dedicated monitoring and procedures for early diagnosis.
Copyright © 2014 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  BRCA2; Cancer de prostate; Dépistage; Genetic predisposition; Génétique; HOXB13; Hereditary; Héréditaire; Prostate cancer; Prédisposition; Susceptibility; Susceptibilité

Mesh:

Substances:

Year:  2014        PMID: 25609482     DOI: 10.1016/j.bulcan.2014.12.007

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  1 in total

1.  Influence of a single-nucleotide polymorphism of the DNA mismatch repair-related gene exonuclease-1 (rs9350) with prostate cancer risk among Chinese people.

Authors:  Yiming Zhang; Pengju Li; Abai Xu; Jie Chen; Chao Ma; Akiko Sakai; Liping Xie; Lei Wang; Yanqun Na; Haruki Kaku; Peng Xu; Zhong Jin; Xiezhao Li; Kai Guo; Haiyan Shen; Shaobo Zheng; Hiromi Kumon; Chunxiao Liu; Peng Huang
Journal:  Tumour Biol       Date:  2015-12-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.